Ideas to Action:

Independent research for global prosperity

Publications

 

June 23, 2010

FDA’s Role in Improving the Development Pathway for Neglected Disease Therapies - Congressional Testimony

Visiting Fellow Tom Bollyky testified before the U.S. Senate Appropriations Subcommittee on Agriculture, Rural Development, the Food and Drug Administration, and Related Agencies on how the FDA can help develop programs for neglected diseases. Programs for neglected diseases, such as tuberculosis, malaria and other parasitic illnesses, lack a regulatory infrastructure to ensure programs work properly.

June 14, 2010

The Race Against Drug Resistance (brief)

The Center for Global Development’s Drug Resistance Working Group urges pharmaceutical companies, governments, donors, global health institutions, health providers, and patients to collectively and immediately tackle this global health threat by implementing four key recommendations.

June 14, 2010

The Race Against Drug Resistance

In an increasingly interconnected world, drug resistance does not stop at a patient’s bedside—it threatens global health. The conclusions of the Center for Global Development’s Drug Resistance Working Group make clear the need for urgent action to address this growing crisis.

Rachel Nugent , Emma Back and Alexandra Beith
June 1, 2010

Sustaining and Leveraging AIDS Treatment

In the final installation of a three-part series, Mead Over estimates the fiscal burden of international AIDS treatment programs, and suggests ways that donors, governments, and patients can sustain current treatments while preventing future cases.